VR Logo

Solvay Pharma India Ltd. download report


Healthcare | Drugs & Pharma

Solvay Pharma India Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2010 Solvay Pharma India Ltd. Annual Report
2009 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2008 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2007 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2006 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2005 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2004 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2003 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2002 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes
2001 Solvay Pharma India Ltd. Annual Report Solvay Pharma India Ltd. chairman speech Solvay Pharma India Ltd. director's report Solvay Pharma India Ltd. management discussion Solvay Pharma India Ltd. corporate governance Solvay Pharma India Ltd. auditor's report Solvay Pharma India Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1999

Chairman: Roland Kaut

Managing Director: Niteen B Gadgil

Group: Solvay Pharma - MNC

Listing: BSE: 532447

Country: India

Headquarters: Mumbai, Maharashtra

Website: www.solvaypharma.co.in

Key Facts

Market cap: ₹1,081.42 Cr

Revenue (TTM): 294.73 Cr

Earnings (TTM): 50.85 Cr

Cash: 87.81 Cr

Total Debt: 0.00 Cr

Promoters' ownership: 88.85%

Liquidity:

52 Week range: ₹-- - --

Face value: 10.00

Shares outstanding: 50,49,706

10 Years Aggregate:

  • CFO: 195.53 Cr
  • EBITDA: 365.62 Cr
  • Net Profit: 242.69 Cr

Stock Performance

Time Period S&P BSE Sensex S&P BSE Healthcare
YTD-8.71-17.06--
1 month-3.11-3.28--
3 months-7.30-10.69--
1 Year0.48-13.41--
3 Years10.3419.05--
5 Years11.439.23--
10 Years12.1012.39--
As on 28-Jun-2022